(Q39153193)

9 September 2017

title

Cancer targeting gene-viro-therapy for pancreatic cancer using oncolytic adenovirus ZD55-IL-24 in immune-competent mice (English)

1 reference

9 September 2017

1 reference

1 reference

1 reference

Bin He

1

1 reference

9 September 2017

Xiuyan Huang

series ordinal

2

1 reference

9 September 2017

Xinyuan Liu

series ordinal

3

1 reference

9 September 2017

Bin Xu

series ordinal

4

1 reference

9 September 2017

publication date

11 May 2013

1 reference

Molecular Biology Reports

9 September 2017

published in

1 reference

9 September 2017

volume

40

1 reference

9 September 2017

issue

9

1 reference

9 September 2017

page(s)

5397-5405

1 reference

9 September 2017

cites work

Cancer statistics, 2010

1 reference

https://api.crossref.org/works/10.1007%2FS11033-013-2638-8

T cell immunoglobulin- and mucin-domain-containing molecule 3 gene polymorphisms and susceptibility to pancreatic cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11033-013-2638-8

An armed oncolytic adenovirus system, ZD55-gene, demonstrating potent antitumoral efficacy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11033-013-2638-8

Fighting fire with fire: rewiring tumor cells for oncolytic virotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11033-013-2638-8

Oncolytic virotherapy for hematological malignancies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11033-013-2638-8

Oncolytic virotherapy in veterinary medicine: current status and future prospects for canine patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11033-013-2638-8

An adenovirus mutant that replicates selectively in p53-deficient human tumor cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11033-013-2638-8

Late viral RNA export, rather than p53 inactivation, determines ONYX-015 tumor selectivity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11033-013-2638-8

mda-7/IL-24: multifunctional cancer-specific apoptosis-inducing cytokine

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11033-013-2638-8

Antitumor activity of an adenovirus harboring human IL-24 in colon cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11033-013-2638-8

Mechanism of in vitro pancreatic cancer cell growth inhibition by melanoma differentiation-associated gene-7/interleukin-24 and perillyl alcohol

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11033-013-2638-8

Molecular target-based therapy of pancreatic cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11033-013-2638-8

Strategy of Cancer Targeting Gene-Viro-Therapy (CTGVT) a trend in both cancer gene therapy and cancer virotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11033-013-2638-8

Potent antitumor activity of oncolytic adenovirus expressing mda-7/IL-24 for colorectal cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11033-013-2638-8

Enhanced antitumor activity by a selective conditionally replicating adenovirus combining with MDA-7/interleukin-24 for B-lymphoblastic leukemia via induction of apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11033-013-2638-8

Inhibition of autophagy induced by overexpression of mda-7/interleukin-24 strongly augments the antileukemia activity in vitro and in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11033-013-2638-8

An armed oncolytic adenovirus ZD55-IL-24 combined with ADM or DDP demonstrated enhanced antitumor effect in lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11033-013-2638-8

Conditionally replicating adenoviruses carrying mda-7/IL-24 for cancer therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11033-013-2638-8

Oncolytic virus-mediated manipulation of DNA damage responses: synergy with chemotherapy in killing glioblastoma stem cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11033-013-2638-8

Treatment of pancreatic cancer using an oncolytic virus harboring the lipocalin-2 gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11033-013-2638-8

Intravenous delivery of a multi-mechanistic cancer-targeted oncolytic poxvirus in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11033-013-2638-8

Immunotherapy: Seek and destroy: oncolytic virus shows promise in phase I trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11033-013-2638-8

Gene and viral therapy for glioblastoma: a review of clinical trials and future directions

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11033-013-2638-8

Thunder and lightning: immunotherapy and oncolytic viruses collide

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11033-013-2638-8

Intratumoral injection of INGN 241, a nonreplicating adenovector expressing the melanoma-differentiation associated gene-7 (mda-7/IL24): biologic outcome in advanced cancer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11033-013-2638-8

mda-7/IL-24: a unique member of the IL-10 gene family promoting cancer-targeted toxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11033-013-2638-8

The development of MDA-7/IL-24 as a cancer therapeutic

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11033-013-2638-8

Induction and chemotherapeutic response of two transplantable ductal adenocarcinomas of the pancreas in C57BL/6 mice.

21 January 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/23666064

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Clinical and local biological effects of an intratumoral injection of mda-7 (IL24; INGN 241) in patients with advanced carcinoma: a phase I study

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/23666064

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

A combinatorial approach for selectively inducing programmed cell death in human pancreatic cancer cells

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/23666064

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1007/S11033-013-2638-8

1 reference

9 September 2017

1 reference